By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AcelRx Pharmaceuticals 

575 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-216-3500 Fax: 650-216-6500




Company News
AcelRx (ACRX) To Hold First Quarter Financial Results Conference Call And Webcast On Monday, May 2nd, 2016 4/28/2016 6:59:31 AM
AcelRx (ACRX) Names Howard B. Rosen as Permanent CEO, Revises Pipeline Priorities for 2016 3/30/2016 6:56:56 AM
AcelRx (ACRX) Publishes A Review Of Hospital-Based Opioid Patient-Controlled Analgesia, Risks And Pharmacoeconomics 3/25/2016 6:56:09 AM
AcelRx (ACRX) Advances ARX-04 Into Extension Phase Of Open-Label Phase 3 Emergency Room Study 3/14/2016 5:58:16 AM
AcelRx (ACRX) Provides Corporate Update And Reports Fourth Quarter And Full Year 2015 Financial Results 3/8/2016 6:38:00 AM
AcelRx (ACRX) Initiates Phase 3 Study Of ARX-04 In Patients With Post-Operative Moderate-To-Severe Acute Pain 3/7/2016 6:33:45 AM
AcelRx (ACRX) To Hold Annual 2015 Financial Results Conference Call And Webcast On Monday, March 7th, 2016 3/3/2016 10:35:13 AM
AcelRx (ACRX) To Present At Two Upcoming Investor Events In March 3/1/2016 9:41:09 AM
AcelRx (ACRX)'s Pain Drug Shows Positive Results In Late-Stage Trial 2/25/2016 6:12:06 AM
AcelRx (ACRX) Presents Phase 3 Results From ARX-04 Clinical Program At JAB Burn And Wound Care Symposium 2/11/2016 7:00:30 AM